Ultrasensitive Nanoimmunosensor by coupling non-covalent functionalized graphene oxide platform and numerous ferritin labels on carbon nanotubes

Biosensors & Bioelectronics
Rashida AkterMd Aminur Rahman

Abstract

An ultrasensitive electrochemical nanostructured immunosensor for a breast cancer biomarker carbohydrate antigen 15-3 (CA 15-3) was fabricated using non-covalent functionalized graphene oxides (GO/Py-COOH) as sensor probe and multiwalled carbon nanotube (MWCNTs)-supported numerous ferritin as labels. The immunosensor was constructed by immobilizing a monoclonal anti-CA 15-3 antibody on the GO modified cysteamine (Cys) self-assembled monolayer (SAM) on an Au electrode (Au/Cys) through the amide bond formation between the carboxylic acid groups of GO/Py-COOH and amine groups of anti-CA 15-3. Secondary antibody conjugated MWCNT-supported ferritin labels (Ab2-MWCNT-Ferritin) were prepared through the amide bond formation between amine groups of Ab2 and ferritin and carboxylic acid groups of MWCNTs. The detection of CA 15-3 was based on the enhanced bioelectrocatalytic reduction of hydrogen peroxide mediated by hydroquinone (HQ) at the GO/Py-COOH-based sensor probe. The GO/Py-COOH-based sensor probe and Ab2-MWCNT-Ferritin labels were characterized using cyclic voltammetry (CV), electrochemical impedance spectroscopy (EIS), scanning electron microscope (SEM), transmission electron microscope (TEM), and x-ray photoelectron spectroscop...Continue Reading

References

Oct 1, 1985·Analytical Chemistry·W R Heineman, H B Halsall
May 1, 1997·Nature Biotechnology·A P Turner
Jul 18, 2001·Journal of the American Chemical Society·R J ChenH Dai
Dec 6, 2001·Annals of Clinical Biochemistry·A M WardF C Hamdy
Dec 31, 2002·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Zhihui HeWenrui Jin
Dec 19, 2003·The Urologic Clinics of North America·Matthew B Gretzer, Alan W Partin
Mar 16, 2005·Accounts of Chemical Research·Xiaofeng Liu, Elizabeth C Theil
Sep 20, 2005·Nature Biotechnology·Gengfeng ZhengCharles M Lieber
Aug 24, 2006·Journal of the American Chemical Society·Xin YuJames F Rusling
Nov 1, 2006·Analytical Chemistry·Guodong LiuYuehe Lin
Dec 29, 2006·Small·Pompi HazarikaChristof M Niemeyer
Apr 15, 2008·Biosensors & Bioelectronics·Guifen JieJun-Jie Zhu
Jun 13, 2009·Biosensors & Bioelectronics·Shradha PrabhulkarChen-Zhong Li
Sep 22, 2009·Biosensors & Bioelectronics·Simona ScaranoMaria Minunni
Jun 16, 2010·Chemical Reviews·Nikolaos KarousisDimitrios Tasis
Sep 8, 2010·Clinica Chimica Acta; International Journal of Clinical Chemistry·Michael J DuffyEnda W McDermott
Jul 29, 2011·Chemical Society Reviews·Maëlle PerfézouArben Merkoçi
Dec 3, 2014·Clinica Chimica Acta; International Journal of Clinical Chemistry·Dorit Di GioiaPetra Stieber
Jul 15, 2015·Clinica Chimica Acta; International Journal of Clinical Chemistry·Petra StieberDorit Di Gioia

❮ Previous
Next ❯

Citations

Jul 29, 2017·Chemical Reviews·Zdeněk FarkaPetr Skládal
May 8, 2018·Journal of Drug Targeting·Lingyun YiGuangxi Zhai
Jul 5, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Baozhen WangJun-Ichi Anzai
Jul 24, 2020·Sensors·Veronika GajdosovaJan Tkac
Mar 30, 2018·Mikrochimica Acta·Ankita SinhaNimisha Jadon
Jun 5, 2018·Analytical Chemistry·Md Rajibul Akanda, Huangxian Ju
Jan 19, 2021·ACS Biomaterials Science & Engineering·Zahra Mohammadpour, Keivan Majidzadeh-A

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biosensors for Cancer Detection

Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents.